Appraising the causal relevance of DNA methylation for risk of lung cancer
Thomas Battram(University of Bristol), Caroline L. Relton(Newcastle College), Laura Baglietto, Gibran Hemani(Bristol City Council), Graham G. Giles(The University of Melbourne), Florence Guida(Centre international de recherche sur le cancer), Vittorio Perduca(Délégation Paris 5), Christopher I. Amos(The University of Texas MD Anderson Cancer Center), Mattias Johansson(Centre international de recherche sur le cancer), Tom R. Gaunt(MRC Epidemiology Unit), Andrew E. Teschendorff(Shanghai Institute of Nutrition and Health), Silvia Polidoro(Cancer Prevention Institute of California), Philip Haycock(University of Bristol), Joshua R. Freeman(University of Massachusetts Amherst), Therese Haugdahl Nøst(UiT The Arctic University of Norway), Rebecca C. Richmond(John Radcliffe Hospital), Kjell Grankvist(Umeå University), Stig E. Bojesen(University of Copenhagen), Robert Carreras‐Torres(Institut de Biologia Evolutiva), Børge G. Nordestgaard(Gentofte Hospital), Paolo Vineis(Imperial College London), Allison Hodge(The University of Melbourne), Gianluca Severi(Inserm), George Davey Smith(University of Bristol), Mikael B Johansson(Centre international de recherche sur le cancer), Torkjel M. Sandanger(UiT The Arctic University of Norway)
Cited by 79
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
A reference panel of 64,976 haplotypes for genotype imputation
|Nature Genetics|2016|3.3k